FilingSEC EDGAR8-K
Valion Bio Appoints Thomas Jensen as New Board Chair
· SEC accepted
StageManagement Change
Filing content
Valion Bio appointed Thomas Jensen as its new Board Chair, aiming to leverage his turnaround experience to advance the development of Entolimod.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…